Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Conditions: Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Early Stage Triple-Negative Breast Carcinoma Interventions: Biological: Pembrolizumab; Other: Patient Observation; Procedure: Biopsy; Procedure: Biospecimen Collection; Other: Questionnaire Administration; Other: Quality-of-Life Assessment Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2023 Category: Research Source Type: clinical trials
Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA
Conditions: Hormone Receptor Positive Breast Carcinoma; Breast Neoplasms; Neoplasms, Breast; Breast Diseases; Antineoplastic Agents; Aromatase Inhibitors; ESR1 Gene Mutation Intervention: Diagnostic Test: Liquid biopsy and CT scan Sponsor: Centro di Riferimento Oncologico - Aviano Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2023 Category: Research Source Type: clinical trials
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Conditions: Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Early Stage Triple-Negative Breast Carcinoma Interventions: Biological: Pembrolizumab; Other: Patient Observation; Procedure: Biopsy; Procedure: Biospecimen Collection; Other: Questionnaire Administration; Other: Quality-of-Life Assessment Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2023 Category: Research Source Type: clinical trials
Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA
Conditions: Hormone Receptor Positive Breast Carcinoma; Breast Neoplasms; Neoplasms, Breast; Breast Diseases; Antineoplastic Agents; Aromatase Inhibitors; ESR1 Gene Mutation Intervention: Diagnostic Test: Liquid biopsy and CT scan Sponsor: Centro di Riferimento Oncologico - Aviano Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2023 Category: Research Source Type: clinical trials
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Conditions: Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Early Stage Triple-Negative Breast Carcinoma Interventions: Biological: Pembrolizumab; Other: Patient Observation; Procedure: Biopsy; Procedure: Biospecimen Collection; Other: Questionnaire Administration; Other: Quality-of-Life Assessment Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2023 Category: Research Source Type: clinical trials
Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA
Conditions: Hormone Receptor Positive Breast Carcinoma; Breast Neoplasms; Neoplasms, Breast; Breast Diseases; Antineoplastic Agents; Aromatase Inhibitors; ESR1 Gene Mutation Intervention: Diagnostic Test: Liquid biopsy and CT scan Sponsor: Centro di Riferimento Oncologico - Aviano Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2023 Category: Research Source Type: clinical trials
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Conditions: Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Early Stage Triple-Negative Breast Carcinoma Interventions: Biological: Pembrolizumab; Other: Patient Observation; Procedure: Biopsy; Procedure: Biospecimen Collection; Other: Questionnaire Administration; Other: Quality-of-Life Assessment Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2023 Category: Research Source Type: clinical trials
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer
Condition: Breast Carcinoma Interventions: Other: Best Practice; Other: Medical Device Usage and Evaluation; Procedure: Respiratory Muscle Training; Other: Survey Administration Sponsor: Roswell Park Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2023 Category: Research Source Type: clinical trials
